Close Menu

Helomics

The company operates three subsidiaries including Helomics, which provides tumor-analysis services for treatment personalization and new drug development.

The groups will use Helomics' artificial intelligence-based platform to develop tools to provide predictive therapeutic recommendations for ovarian and thyroid cancers.